Contemporary clinical trials in uterine corpus malignancies.
- Author:
Hee Sug RYU
1
Author Information
1. Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea. hsryu@ajou.ac.kr
- Publication Type:Review ; Clinical Trial
- Keywords:
Endometrial cancer;
Uterine sarcoma;
Clinical trials
- MeSH:
Endometrial Neoplasms;
Female;
Humans;
Incidence;
Korea;
Mortality;
Uterine Neoplasms
- From:Korean Journal of Obstetrics and Gynecology
2007;50(10):1299-1307
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Uterine cancer is the most common gynecologic malignancy in Western countries. In Korea, its incidence has been rising, and the increased incidence is associated with a rising death rate. The first two decades of endometrial cancer study by the GOG began with a prospective, surgicopathologic staging trial that was the cornerstone for development of all subsequent trials. The therapeutic strategies were tailored to disease extent - low risk, intermediate risk, and high risk groups of patients. There were great advances in the area of chemotherapeutic agents through a number of extensive phase II trials. New trials of these agents have been opened for the patients with advanced or recurrent uterine cancers.
